P53 and beta-catenin in colorectal cancer progression

Current Pharmaceutical Design

Volumn 9, Issue 24, 2003, Pages 1932-1936

  Valentini, Anna Maria ^a   Pirrelli, Michele ^a   Renna, Letizia ^a   Armentano, Raffaele ^a   Caruso, Maria Lucia ^a  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

Author keywords

Beta catenin; Colorectal adenoma; Immunohistochemistry; p53

Indexed keywords

ADENOVIRUS VECTOR; ANTINEOPLASTIC AGENT; APC PROTEIN; BETA CATENIN; PARAFFIN; PROTEIN P53;

CANCER GROWTH; CANCER INVASION; CELL NUCLEUS; CLINICAL ARTICLE; COLON ADENOMA; COLON CARCINOGENESIS; COLON POLYP; COLORECTAL CANCER; CONTROLLED STUDY; CYTOPLASM; DYSPLASIA; EPITHELIUM; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; TISSUE FIXATION; TUMOR CELL;

ADENOMA; BETA CATENIN; CADHERINS; COLORECTAL NEOPLASMS; CYTOSKELETAL PROTEINS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MUTATION; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0042178353     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612033454216     Document Type: Review

References (30)

1. Munemitsu S, Albert I, Souza B, Rubinfield B, Polakis P. Proc Natl Acad Sci USA 1995; 92: 3046-3050.
2. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, et al. Science 1997; 275: 1784-1787.
3. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, et al. Science 1997; 275: 1787-1790.
4. Polakis P. Curr Opin Genet Dev 1999; 9: 15-21.
5. Chiarugi V, Ruggiero M. Tumori 1996; 82: 205-209.
6. Maki CG, Huibregtse JM, Howley PM. Cancer Res 1996; 56: 2649-2654.
7. Sadot E, Geiger B, Oren M, Ben-Ze'ev. Mol Cell Biol 2001; 21: 6768-81.
8. Damalas A, Ben-Ze'ev A, Simcha I, Shtutman M, Leal JFM, Zhurinsky J, et al. The EMBO J 1999; 18: 3054-3063.
9. Gafà R, Lanza G. Patologica 1998; 90: 351-356.
10. Edmoston TB, Cuesta HK, Burkholder S, Barusevicius A, Rose D, Kovatich AJ, et al. Hum Pathol 2000; 31: 1506-1514.
11. Valentini AM, Renna L, Armentano R, Pirrelli M, Di Leo A, Gentile M, et al. Anticancer Res 2002; 22: 2083-88.
12. El-Bahrawy MA, Poulsom R, Jeffery R, Talbot I, Alison MR. Hum Pathol 2001; 32: 1216-1224.
13. Peifer M. Science 1997; 275: 1752-1753.
14. Morin PJ. Bioassay 1999; 21: 1021-30.
15. Hiscox S, Jiang WG. Anticancer Res 1997; 17: 1349-1354.
16. Kobayashi M, Honma T, Matsuda Y, Suzuki Y, Narisawa R, Ajioka Y, et al. Br J Cancer 2000; 82(10): 1689-1693.
17. Hugh TJ, Dillon SA, O'Dowd G, Getty B, Pignatelli M, Poston GJ, et al. Int J Cancer 1999; 82: 504-11.
18. Speroni AH, Vanzulli SI, Meiss RP. Endoscopy 1998; 30 (7): 623-6.
19. Valentini AM, Pirrelli M, Caruso ML. Exp Clin Cancer Res 1995; 14: 139-44.
20. Cunningham J, Lust JA, Schaid DJ, Bren GD, Carpenter HA, Rizza E, et al. Cancer Res 1992; 52: 1974-1980.
21. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, et al. Science 1989; 244: 217-22.
22. Smith G, Carey FA, Beattie J, Wilkie MJ, Lighfoot TJ, Coxhead J, et al. Proc Natl Acad Sci USA 2002; 99: 9433-38,
23. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M. N Engl J Med 1988; 319: 525-32.
24. Brabletz T, Jung A, Harmann K, Gunther K, Hohenberger W, Kirchner T. Pathol Res Pract 1998; 194: 701-704.
25. Sanding V, Brand K, Herwig S, Lukas J, Bartek J, Strauss M. Nature Med 1997; 3: 313-19.
26. Nielsen LL, Maneval DC. Cancer Gene Ther 1998; 5: 52-63.
27. Badie B, Kramar MH, Lau R, Boothman DA, Economou JS, Black KL. J Neurooncol 1998; 37: 217-22.
28. Anderson WF, Umar A, Viner JL, Hawk ET. The role of cyclooxygenase inhibitors in cancer prevention. Curr Pharm Des 2002; 8(12): 1035-62.
29. Chauhan DP. Chemotherapeutic potential of curcumin for colorectal cancer. Curr Pharm Des 2002; 8(19): 1695-706.
30. Westphal EM, Melchner Hv H. Gene therapy approaches for the selective killing of cancer cells. Curr Pharm Des 2002; 8(19): 1683-94.